Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: Results from the Third National Health and Nutrition Examination Survey

Journal of Women's Health

Volumn 13, Issue 6, 2004, Pages 713-718

  Ward, Michael M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PHYSICIAN; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIMALARIALS; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEDICAL RECORDS; MIDDLE AGED; ODDS RATIO; PREVALENCE; PRIMARY PREVENTION; QUESTIONNAIRES; UNITED STATES; WOMEN'S HEALTH;

EID: 4644329358     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2004.13.713     Document Type: Article

References (22)

1. Cooper GS, Dooley MA, Treadwell EL, St. Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 1998;41:1714.
2. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999;42:46.
3. Tsao BP. The genetics of systemic lupus erythematosus. Trends Immunol 2003;24:595.
4. Siegel M, Holley HL, Lee SL. Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956-1965. Arthritis Rheum 1970;13:802.
5. Kurland LT, Hauser WA, Ferguson RH, Holley KE. Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn, 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc 1969;44:649.
6. Fessel WJ. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome and first symptoms: The high prevalence in black women. Arch Intern Med 1974;134:1027.
7. Serdula MK, Rhoads GG. Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 1979;22:328.
8. Michet CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clinic Proc 1985;60:105.
9. Maskarinec G, Katz AR. Prevalence of systemic lupus erythematosus in Hawaii: Is there a difference between ethnic groups? Hawaii Med J 1995;54:406.
10. Hochberg MC, Perlmutter DL, Medsger TA, et al. Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 1995;4:454.
11. Lahita RG. Special report: Adjusted lupus prevalence. Results of a marketing study by the Lupus Foundation of America. Lupus 1995;4:450.
12. Balluz L, Philen R, Ortega L, et al. Investigation of systemic lupus erythematosus in Nogales, Arizona. Am J Epidemiol 2001;154:1029.
13. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. National Center for Health Statistics. Vital Health Stat 1994; 1:32.
14. U.S. Department of Health and Human Services (DHHS). National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994. NHANES III Household Adult Data File (CD-ROM). Public Use Data File Documentation Number 77560. Hyattsville, MD: Centers for Disease Control and Prevention, 1996. Available from National Technical Information Service (NTIS), Springfield, VA.
15. U.S. Department of Health and Human Services (DHHS). National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994. NHANES III Prescription Medicines Data File. Public Use Data File (CD-ROM Series 11, Number 2a). Hyattsville,. MD: Centers for Disease Control and Prevention, 1998. Available from National Technical Information Service (NTIS), Springfield, VA.
16. Liang MH, Karlson EW. Prevalence of SLE: Higher or lower? Lupus 1995;4:421.
17. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778.
18. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271.
19. Petri M, Lakatta C, Magder L, Goldman D. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis. Am J Med 1994;96:254.
20. Alarcon GS, Friedman AW, Straaton KV, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. Lupus 1999;8:197.
21. McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 1995;38:1260.
22. Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223.